215 cardiovascular disease drugs in the pipeline, report finds

06/13/2013 | Drug Store News · PharmaTimes (U.K.)

A total of 215 drugs for heart disease and stroke are awaiting FDA approval or are in clinical trials, according to a report from the Pharmaceutical Research and Manufacturers of America. The lineup includes 30 for heart failure, 29 for lipid disorders, 19 for stroke and 17 for hypertension.

View Full Article in:

Drug Store News · PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT